Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.32 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.32 |
| ▸ | AKT1 | P31749 | 5/20 | 0.32 |
| ▸ | AKT2 | P31751 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | SMO | Q99835 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29529042 | 0.96 | KDM4E (0.35) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528457 | 0.93 | KDM4E (0.36) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528674 | 0.93 | KDM4E (0.37) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528823 | 0.92 | KDM4E (0.35) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528317 | 0.90 | KDM4E (0.36) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528665 | 0.85 | MAPT (0.38) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528658 | 0.85 | MAPT (0.38) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528981 | 0.85 | MAPT (0.38) | KDM4EMAPTBRD4TP53NPC1 | |
| SCHEMBL29528650 | 0.85 | MAPT (0.42) | KDM4EMAPTBRD4NPC1PKM | |
| SCHEMBL29528249 | 0.83 | MAPT (0.40) | KDM4EMAPTBRD4TP53NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11283027-B1 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2022-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11283027-B1 | Composition of matter for use in organic light-emitting diodes | ALDH1A2, CYBA, CRY2 | KDM4E 4331/4885MAPT 214/4885BRD4 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.